Rationally Designing Safer Anilines: The Challenging Case of 4-Aminobiphenyls
Bradley Shaw2017-11-07T14:25:25+00:0070) Rationally Designing Safer Anilines: The Challenging Case of 4-Aminobiphenyls Birch, A. M.; Groombridge,
70) Rationally Designing Safer Anilines: The Challenging Case of 4-Aminobiphenyls Birch, A. M.; Groombridge,
71) Protein–Ligand Crystal Structures Can Guide the Design of Selective Inhibitors of the FGFR
72) Use of Small-Molecule Crystal Structures To Address Solubility in a Novel Series of
73) “Protein–Ligand Crystal Structures Can Guide the Design of Selective Inhibitors of the FGFR
74) “Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment
75) A System for Encoding and Searching Markush Structures Cosgrove, D. A.; Green, K.
76) (1R,2R)-N-(1-Cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): A Potent and Highly Selective Cathepsin K Inhibitor for the Treatment
77) Isosteric replacements for benzothiazoles and optimisation to potent Cathepsin K inhibitors free from
78) A matched molecular pair analysis of in vitro human microsomal metabolic stability measurements
79) A matched molecular pair analysis of in-vitro human microsomal metabolic stability measurements for
41 Avada Avenue, Florida, 98765
403-904-3623